5 things to know before the stock market opens Wednesday
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. In addition to…
Jim Cramer says achieving early retirement comes down to just 3 key assets in your investment portfolio
Robin Marchant / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in…
Microsoft’s $440 billion wipeout, and investors angry about OpenAI’s debt, explained
Wall Street’s yearslong bet on AI is facing a severe test on Thursday, as investors might begin to…
Nvidia CEO Jensen Huang says AI won’t be the job killer everyone fears. Here’s why
Nvidia CEO Jensen Huang said Wednesday that artificial intelligence will lead to more jobs, not fewer. In an…
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
I talked to many health CEOs out West and see big things for drug stocks
We get so caught up in the buzz and the sizzle that we forget about the steak, especially…
“It Doesn’t Have Growth, and That’s the Real Problem”
Sirius XM Holdings Inc. (NASDAQ:SIRI) is one of the stocks on Jim Cramer’s radar recently. During the episode,…
This energy stock is the clearest winner in efforts aimed at powering the AI buildout
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
Forget the bubble talk — why you need to own AI stocks in 2026
I am tired of the lies, exaggerations, and dispersions that are constantly told in the assault on the…
Jim Cramer Slams ‘Big Freakout’ Selling In Nvidia, AI, Crypto Stocks After Strong GDP Print: ‘It Is Just Stupid’
Market commentator and popular TV personality Jim Cramer vented frustration Tuesday over strong economic data triggering panic in high-growth sectors…
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
Jim Cramer looks back at 2025’s biggest market themes
As the year comes to an end, CNBC’s Jim Cramer revisited questions he asked at the start of…